Moving Past "Treatment-Resistant" Depression: The 71% Success Story That Changes Everything
Clay Clay

Moving Past "Treatment-Resistant" Depression: The 71% Success Story That Changes Everything

If you've been told your depression is "treatment-resistant," those words probably felt like a life sentence. After cycling through medication after medication without real relief, many of us start to believe there's something fundamentally broken about our brains that can't be fixed. But what if the problem isn't with you at all? What if the treatments themselves have been inadequate, and the label "treatment-resistant" is just a way to avoid admitting that our current approaches are failing the people who need help most?

Read More
Breaking Free from the Antidepressant Trap: Why Two Psilocybin Sessions Beat Daily Antidepressant Pills
Clay Clay

Breaking Free from the Antidepressant Trap: Why Two Psilocybin Sessions Beat Daily Antidepressant Pills

For decades, we've been told that depression is a "chemical imbalance" that requires daily medication to manage. This story has made pharmaceutical companies billions while leaving countless people cycling through different pills, hoping the next one will finally work. The truth is sobering: traditional antidepressants help only about 30-40% of people achieve real recovery. Meanwhile, side effects like emotional numbness, sexual dysfunction, and weight gain often make life feel hollow even when depression symptoms improve slightly.

Read More
Psychedelic-Assisted Therapy for OCD
Clay Clay

Psychedelic-Assisted Therapy for OCD

Research suggests that psychedelic assisted therapy might offer real hope for people suffering from OCD. Significant ground work has been laid for the treatment of OCD with psilocybin and outcomes look promising.

Read More
Investigating the Neuroregenerative and Neuroprotective Properties of Psilocybin in Humans
Clay Clay

Investigating the Neuroregenerative and Neuroprotective Properties of Psilocybin in Humans

Psilocybin, the active compound in psychedelic mushrooms, has garnered significant attention for its potential therapeutic effects on the brain. Recent research has explored its capacity to promote neuroregeneration and offer neuroprotection, which could be pivotal in treating various neurological and psychiatric disorders. This investigation synthesizes findings from multiple studies to determine whether psilocybin exhibits these properties in humans.

Read More